Nivolumab is an anti-programmed cell death protein 1 monoclonal antibody that is used to treat metastatic cutaneous malignant melanoma. Although bilateral uveitis has been reported as a side effect of nivolumab administration. there are few reports of Vogt-Koyanagi-Harada disease (VKH)-like uveitis. We report such a case. https://jalyttlers.shop/product-category/pizza-cutter/
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Internet 1 hour 50 minutes ago obxpkmpp5pb7Web Directory Categories
Web Directory Search
New Site Listings